Annual FCF
-$158.83 M
-$23.27 M-17.16%
31 December 2023
Summary:
Verve Therapeutics annual free cash flow is currently -$158.83 million, with the most recent change of -$23.27 million (-17.16%) on 31 December 2023. During the last 3 years, it has fallen by -$120.14 million (-310.54%). VERV annual FCF is now -1608.05% below its all-time high of -$9.30 million, reached on 31 December 2019.VERV Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$40.54 M
-$5.41 M-15.38%
30 September 2024
Summary:
Verve Therapeutics quarterly free cash flow is currently -$40.54 million, with the most recent change of -$5.41 million (-15.38%) on 30 September 2024. Over the past year, it has dropped by -$27.67 million (-214.97%). VERV quarterly FCF is now -451.91% below its all-time high of -$7.35 million, reached on 30 September 2020.VERV Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$162.06 M
-$27.67 M-20.59%
30 September 2024
Summary:
Verve Therapeutics TTM free cash flow is currently -$162.06 million, with the most recent change of -$27.67 million (-20.59%) on 30 September 2024. Over the past year, it has dropped by -$8.23 million (-5.35%). VERV TTM FCF is now -1957.92% below its all-time high of -$7.88 million, reached on 31 March 2020.VERV TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.2% | -215.0% | -5.3% |
| 3 y3 years | -310.5% | -81.3% | -134.4% |
| 5 y5 years | - | - | - |
VERV Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -310.5% | at low | -215.0% | +22.7% | -134.4% | +6.2% |
| 5 y | 5 years | -1608.0% | at low | -451.9% | +22.7% | -1957.9% | +6.2% |
| alltime | all time | -1608.0% | at low | -451.9% | +22.7% | -1957.9% | +6.2% |
Verve Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$40.54 M(+15.4%) | -$162.06 M(+20.6%) |
| June 2024 | - | -$35.14 M(-19.3%) | -$134.39 M(-10.3%) |
| Mar 2024 | - | -$43.52 M(+1.5%) | -$149.88 M(-5.6%) |
| Dec 2023 | -$158.83 M(+17.2%) | -$42.87 M(+233.0%) | -$158.83 M(+3.3%) |
| Sept 2023 | - | -$12.87 M(-74.6%) | -$153.83 M(-11.0%) |
| June 2023 | - | -$50.62 M(-3.5%) | -$172.77 M(+13.9%) |
| Mar 2023 | - | -$52.47 M(+38.6%) | -$151.62 M(+11.8%) |
| Dec 2022 | -$135.56 M | -$37.86 M(+19.0%) | -$135.56 M(+7.0%) |
| Sept 2022 | - | -$31.81 M(+7.9%) | -$126.73 M(+8.1%) |
| June 2022 | - | -$29.48 M(-19.1%) | -$117.27 M(+14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$36.41 M(+25.5%) | -$102.44 M(+24.6%) |
| Dec 2021 | -$82.24 M(+112.6%) | -$29.02 M(+29.8%) | -$82.24 M(+18.9%) |
| Sept 2021 | - | -$22.36 M(+52.6%) | -$69.14 M(+27.7%) |
| June 2021 | - | -$14.65 M(-9.6%) | -$54.13 M(+15.1%) |
| Mar 2021 | - | -$16.21 M(+1.8%) | -$47.02 M(+21.5%) |
| Dec 2020 | -$38.69 M(+316.1%) | - | - |
| Dec 2020 | - | -$15.93 M(+116.8%) | -$38.69 M(+70.0%) |
| Sept 2020 | - | -$7.35 M(-2.6%) | -$22.76 M(+47.7%) |
| June 2020 | - | -$7.54 M(-4.3%) | -$15.41 M(+95.7%) |
| Mar 2020 | - | -$7.88 M | -$7.88 M |
| Dec 2019 | -$9.30 M | - | - |
FAQ
- What is Verve Therapeutics annual free cash flow?
- What is the all time high annual FCF for Verve Therapeutics?
- What is Verve Therapeutics annual FCF year-on-year change?
- What is Verve Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Verve Therapeutics?
- What is Verve Therapeutics quarterly FCF year-on-year change?
- What is Verve Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Verve Therapeutics?
- What is Verve Therapeutics TTM FCF year-on-year change?
What is Verve Therapeutics annual free cash flow?
The current annual FCF of VERV is -$158.83 M
What is the all time high annual FCF for Verve Therapeutics?
Verve Therapeutics all-time high annual free cash flow is -$9.30 M
What is Verve Therapeutics annual FCF year-on-year change?
Over the past year, VERV annual free cash flow has changed by -$23.27 M (-17.16%)
What is Verve Therapeutics quarterly free cash flow?
The current quarterly FCF of VERV is -$40.54 M
What is the all time high quarterly FCF for Verve Therapeutics?
Verve Therapeutics all-time high quarterly free cash flow is -$7.35 M
What is Verve Therapeutics quarterly FCF year-on-year change?
Over the past year, VERV quarterly free cash flow has changed by -$27.67 M (-214.97%)
What is Verve Therapeutics TTM free cash flow?
The current TTM FCF of VERV is -$162.06 M
What is the all time high TTM FCF for Verve Therapeutics?
Verve Therapeutics all-time high TTM free cash flow is -$7.88 M
What is Verve Therapeutics TTM FCF year-on-year change?
Over the past year, VERV TTM free cash flow has changed by -$8.23 M (-5.35%)